期刊文献+

门冬氨酸钾镁与葡萄糖酸钙联用防治奥沙利铂神经毒性的临床观察 被引量:16

Clincal observation of the prevention and treatment of the nerve toxicity by combining potassium aspartate and magnesium aspartate and calcium gluconate
下载PDF
导出
摘要 目的:观察门冬氨酸钾镁联用葡萄糖酸钙防治奥沙利铂神经毒性的近期疗效。方法:入选54例患者随机分为A、B两组,两组化疗方案均为含奥沙利铂130mg/m^2的化疗方案,21天为1周期。A组(试验组):门冬氨酸钾镁+葡萄糖酸钙+化疗。B组(对照组):单用化疗。A组在用奥沙利铂之前加用5%葡萄糖溶液250ml+门冬氨酸钾镁20ml+10%葡萄糖酸钙20ml静点,第1~7天,所有患者完成4周期化疗后评价疗效。结果:可评价病例54例,A组28例,发生神经毒性1级5例;2级2例;3级1例,总发生率28.5%。B组26例,发生神经毒性1级9例;2级4例;3级3例,总发生率61.5%。两组有显著性差异(P<0.01)。结论:门冬氨酸钾镁与葡萄糖酸钙联用能降低奥沙利铂神经毒性的发生率,值得临床推广应用。 Objective: To observe the curative effect by combining aspartate and magnesium aspartate and calcium gluconate to prevent and treat the nerve toxicity. Methods:Total of 54 patients were divided into two groups at random, two groups'chemical treatment project both contained oxaliplatin 130mg/m^2 , a rotation was 21 days . A group ( experiment group) add the aspartate and magnesium aspartate and calcium gluconate before use of oxaliplatin from the first to seventh day. B group ( comparison group) used the chemical treatment medicines only. All patients wrere evaluated the curative effect after four weeks chemical treatment. Results : The evaluable cases were 54 cases , group A 28 cases ,in these group nerve toxicity occurred of 1~3 grade in 5,3,1 cases develop rate was 28.5% o group B 26 eases, nerve toxicity of 1 -3 grade occurred in 9,4,3 cases respectively ,develop rate was 61.5%. there was obvious difference between two groups (P 〈 0.01 ). Conclusion: Combining aspartate and magnesium aspartate and calcium glueonate can reduce the clevelopement of the nerve toxicity of oxaliplatin.
出处 《现代肿瘤医学》 CAS 2007年第3期417-418,共2页 Journal of Modern Oncology
关键词 门冬氨酸钾镁 葡萄糖酸钙 奥沙利铂 神经毒性 potassium aspartate and magnesium aspartate calcium gluconate oxaliplatin nerve toxicity
  • 相关文献

参考文献7

二级参考文献24

  • 1王希明.门冬氨酸钾镁治疗慢性酒精中毒性震颤[J].新药与临床,1996,15(2):122-123. 被引量:4
  • 2陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 3陈新谦 金有豫.新编药物学(第13版)[M].北京:人民卫生出版社,1993.365-366.
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5Recchia F,Rea S,Nuzzo A,et al.Multicenter phase Ⅱ study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer,pre-treated with chemotherapy[J].Oncol Rep,2003,10(1):65-69.
  • 6Woynarowski J,Faivres S,Herzig M,et al.Oxaliplatin-induced damage of cellular DNA[J].Mol Pharmacol,2000,58:920-927.
  • 7Grolleau F,Gamelin L,Boisdron-Celle M,et al.A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatinon neuronal voltage-gated sodium channels[J].J Neurophysiol,2001,85:2293-2297.
  • 8Lersch C,Schmelz R,Eckel F,et al.Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer[J].Clin Colorectal Cancer,2002,2(1):54-58.
  • 9孙燕,临床肿瘤内科手术 第3版(第3版),1996年,33-101,214-215页
  • 10Andre T,Bensmaine M, Louvet C, et al. Multicenter phase Ⅱstudy of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J].J Clin Oncol, 1999,17:3560-3568.

共引文献455

同被引文献181

引证文献16

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部